drugset / Trial / NCT05490563
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 2b/3 double blind, randomized, placebo-controlled trial to assess safety and efficacy of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous infusion) for the treatment of adults with spinocerebellar ataxia).
Timeline
- Start
- 2022-06-03
- Primary completion
- 2023-11-24
- Completion
- 2023-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLS-005 | Unknown | 0.5 g/kg | Intravenous |
| Subject | SLS-005 | Unknown | 0.75 g/kg | Intravenous |